Clinical Trial Update: HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors

View source ↗

Summary

HEM-SURVIVE is a structured follow-up study for childhood survivors of hematologic malignancies; the trial is currently NOT_YET_RECRUITING and sponsored by The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | Status: NOT_YET_RECRUITING